Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection

Journal of Clinical Investigation

Volumn 121, Issue 6, 2011, Pages 2336-2349

  Jiang, Xinguo ^a   Khan, Mohammad A ^a   Tian, Wen ^a   Beilke, Joshua ^b   Natarajan, Ramesh ^c   Kosek, Jon ^a   Yoder, Mervin C ^d   Semenza, Gregg L ^e   Nicolls, Mark R ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NOVO NORDISK INC   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANGIOPOIETIN RECEPTOR; CD40 LIGAND MONOCLONAL ANTIBODY; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY LFA 1; PLACENTAL GROWTH FACTOR; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADENOVIRUS; AIRWAY MICROVASCULAR REPAIR; AIRWAY REMODELING; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL DIFFERENTIATION; CELL REGENERATION; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TRANSFER; GRAFT RECIPIENT; IMMUNOTHERAPY; LUNG FIBROSIS; LUNG PERFUSION; LUNG SURGERY; LUNG TRANSPLANTATION; MEDIATOR; MICROVASCULAR SURGERY; MOUSE; NONHUMAN; ORTHOTOPIC TRACHEA TRANSPLANTATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANGIOGENIC PROTEINS; ANIMALS; BRONCHIOLITIS OBLITERANS; CELL HYPOXIA; CELL SURVIVAL; CHEMOKINE CXCL12; ENDOTHELIAL CELLS; GENE THERAPY; GENETIC VECTORS; GRAFT REJECTION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISCHEMIA; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CXCR4; RECOMBINANT FUSION PROTEINS; TRACHEA;

EID: 79957907464     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI46192     Document Type: Article

References (51)

1. Grossman EJ, Shilling RA. Bronchiolitis obliterans in lung transplantation: the good, the bad, and the future. Transl Res. 2009;153(4):153-165.
2. Belperio JA, Weigt SS, Fishbein MC, Lynch JP 3rd. Chronic lung allograft rejection: mechanisms and therapy. Proc Am Thorac Soc. 2009;6(1):108-121.
3. Weigt SS, Wallace WD, Derhovanessian A, Saggar R, Lynch JP, Belperio JA. Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment. Semin Respir Crit Care Med. 2010; 31(2):189-207.
4. Luckraz H, et al. Microvascular changes in small airways predispose to obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant. 2004;23(5):527-531. (Pubitemid 38595735)
5. Luckraz H, Goddard M, McNeil K, Atkinson C, Sharples LD, Wallwork J. Is obliterative bronchiolitis in lung transplantation associated with microvascular damage to small airways? Ann Thorac Surg. 2006;82(4):1212-1218.
6. Bishop GA, Waugh JA, Landers DV, Krensky AM, Hall BM. Microvascular destruction in renal transplant rejection. Transplantation. 1989;48(3):408-414. (Pubitemid 19236503)
7. Matsumoto Y, McCaughan GW, Painter DM, Bishop GA. Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection. Transplantation. 1993;56(1):69-75. (Pubitemid 23220574)
8. Babu AN, et al. Microvascular destruction identifies murine allografts that cannot be rescued from airway fibrosis. J Clin Invest. 2007;117(12):3774- 3785. (Pubitemid 350224088)
9. Semenza GL. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda). 2009;24:97-106.
10. Rey S, Semenza GL. Hypoxia-inducible factor-1- dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res. 2010;86(2):236-242.
11. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia- inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A. 1995;92(12):5510-5514.
12. Bosch-Marce M, et al. Effects of aging and hypoxiainducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res. 2007;101(12):1310-1318. (Pubitemid 350294648)
13. Rey S, et al. Synergistic effect of HIF-1alpha gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia. Proc Natl Acad Sci U S A. 2009; 106(48):20399-20404.
14. Sarkar K, Fox-Talbot K, Steenbergen C, Bosch-Marce M, Semenza GL. Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice. Proc Natl Acad Sci U S A. 2009; 106(44):18769-18774.
15. Ceradini DJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004;10(8):858-864. (Pubitemid 39070860)
16. De Palma M, et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell. 2005;8(3):211-226. (Pubitemid 41317592)
17. Lewis CE, De Palma M, Naldini L. Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2. Cancer Res. 2007;67(18):8429-8432. (Pubitemid 47437413)
18. Pucci F, et al. A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood. 2009;114(4):901-914.
19. Tepper OM, et al. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood. 2005;105(3):1068-1077. (Pubitemid 40170877)
20. Jackson KA, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001;107(11):1395-1402. (Pubitemid 32522033)
21. Tongers J, et al. Haeme oxygenase promotes progenitor cell mobilization, neovascularization, and functional recovery after critical hindlimb ischaemia in mice. Cardiovasc Res. 2008; 78(2):294-300. (Pubitemid 351556094)
22. Sato M, Keshavjee S, Liu M. Translational research: animal models of obliterative bronchiolitis after lung transplantation. Am J Transplant. 2009; 9(9):1981-1987.
23. Dhillon GS, et al. Lung transplant airway hypoxia: a diathesis to fibrosis? Am J Respir Crit Care Med. 2010;182(2):230-236.
24. Murakawa T, et al. Simultaneous LFA-1 and CD40 ligand antagonism prevents airway remodeling in orthotopic airway transplantation: implications for the role of respiratory epithelium as a modulator of fibrosis. J Immunol. 2005;174(7):3869-3879. (Pubitemid 40395959)
25. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005;307(5706):58-62. (Pubitemid 40093472)
26. Gerhardt H, Semb H. Pericytes: gatekeepers in tumour cell metastasis? J Mol Med. 2008;86(2):135-144.
27. Lagaaij EL, Cramer-Knijnenburg GF, van Kemenade FJ, van Es LA, Bruijn JA, van Krieken JH. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet. 2001;357(9249):33-37. (Pubitemid 32056499)
28. Pober JS. Is host endothelium a silver lining for allografts? Lancet. 2001;357(9249):2-3.
29. Semenza GL. Oxygen homeostasis. Wiley Interdiscip Rev Syst Biol Med. 2010;2(3):336-361.
30. Nizet V, Johnson RS. Interdependence of hypoxic and innate immune responses. Nat Rev Immunol. 2009; 9(9):609-617.
31. Sitkovsky M, Lukashev D. Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol. 2005; 5(9):712-721. (Pubitemid 43086172)
32. Kobayashi K, et al. A tissue-engineered trachea derived from a framed collagen scaffold, gingival fibroblasts and adipose-derived stem cells. Biomaterials. 2010;31(18):4855-4863.
33. Mazzone M, et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell. 2009; 136(5):839-851.
34. Al-Lamki RS, Bradley JR, Pober JS. Endothelial cells in allograft rejection. Transplantation. 2008; 86(10):1340-1348.
35. Belperio JA, et al. Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. J Clin Invest. 2001; 108(4):547-556. (Pubitemid 32777734)
36. Gasse P, et al. IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J Clin Invest. 2007; 117(12):3786-3799. (Pubitemid 350224089)
37. Shilling RA, Wilkes DS. Immunobiology of chronic lung allograft dysfunction: new insights from the bench and beyond. Am J Transplant. 2009; 9(8):1714-1718.
38. Dacic S, Yousem SA. Histologic classification of idiopathic chronic interstitial pneumonias. Am J Respir Cell Mol Biol. 2003;29(3 suppl):S5-S9. (Pubitemid 37070301)
39. Phillips RJ, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest. 2004;114(3):438-446. (Pubitemid 39071616)
40. Burlingham WJ, et al. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest. 2007;117(11):3498-3506. (Pubitemid 350097005)
41. Iwano M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens. 2004; 13(3):279-284. (Pubitemid 38582300)
42. Norman JT, Clark IM, Garcia PL. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int. 2000;58(6):2351-2366.
43. Short M, Nemenoff RA, Zawada WM, Stenmark KR, Das M. Hypoxia induces differentiation of pulmonary artery adventitial fibroblasts into myofibroblasts. Am J Physiol Cell Physiol. 2004; 286(2):C416-C425. (Pubitemid 38146366)
44. Du R, et al. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell. 2008;13(3):206-220. (Pubitemid 351318372)
45. Grunewald M, et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell. 2006;124(1):175-189. (Pubitemid 43069318)
46. Hattori K, et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat Med. 2002;8(8):841-849.
47. Kioi M, Vogel H, Schultz G, Hoffman RM, Harsh GR, Brown JM. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest. 2010; 120(3):694-705.
48. Lin EY, et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 2006;66(23):11238-11246. (Pubitemid 46009952)
49. Yang L, et al. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell. 2004;6(4):409-421. (Pubitemid 39361441)
50. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6(4):389-395. (Pubitemid 30208155)
51. Nicolls MR, Zamora MR. Bronchial blood supply after lung transplantation without bronchial artery revascularization. Curr Opin Organ Transplant. 2010;15(5):563-567.